Investor List:

Top Therapeutics Series A Investors in London (9)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Pablo Lubroth, Investor at Hummingbird Ventures
Pablo Lubroth
Sweet spot: $2.8M
Range: $500K - $5.0M
Investors in London, Investors in New York (NY)
Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in DeepTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in DeepTech (Series A), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in DeepTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in DeepTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Therapeutics (Series B), Investors in DeepTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in London (Other Lists), Investors in New York City (Other Lists)
Photo of Andrew Kozlov, Managing Partner at 4BIO Capital
Andrew Kozlov
4BIO Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Dima Kuzmin, Managing Partner at 4BIO Capital
Dima Kuzmin
4BIO Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Andrea Zitna, Partner at Speedinvest
Andrea Zitna
Speedinvest·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Owen Smith, Partner at 4BIO Capital
Owen Smith
4BIO Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Kieran Mudryy, Partner at 4BIO Capital
Kieran Mudryy
4BIO Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Sameer Chandra Anand, Investor at Hoxton Ventures
Sameer Chandra Anand
Hoxton Ventures·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in Cybersecurity (Seed), Investors in SMB Software (Seed), Investors in IoT (Seed), Investors in Data Services (Seed), Investors in Therapeutics (Seed), Investors in AI (Seed), Investors in Cybersecurity (Seed), Investors in SMB Software (Seed), Investors in Data Services (Seed), Investors in IoT (Seed), Investors in AI (Seed), Investors in Therapeutics (Series A), Investors in Cybersecurity (Series A), Investors in IoT (Series A), Investors in SMB Software (Series A), Investors in Data Services (Series A), Investors in Therapeutics (Series A), Investors in AI (Series A), Investors in SMB Software (Series A), Investors in Cybersecurity (Series A), Investors in Data Services (Series A), Investors in IoT (Series A), Investors in AI (Series A), Investors in London (Other Lists)
Photo of Thomas McDonnell, Investor at Business Growth Fund
Thomas McDonnell
Sweet spot: $11.0M
Range: $1.3M - $20.0M
Investors in London
Get new data & insights delivered to your inbox